Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy
Author:
Affiliation:
1. Institute of Genetic Medicine; Newcastle University; Newcastle; UK
2. Peninsula Schools of Medicine and Dentistry; Plymouth University; Plymouth; UK
3. Dubowitz Neuromuscular Centre; University College London; London; UK
Publisher
Wiley
Subject
Clinical Neurology,Developmental Neuroscience,Pediatrics, Perinatology, and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dmcn.12220/fullpdf
Reference27 articles.
1. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus;Drousiotou;Genet Test,1998
2. Population frequencies of neuromuscular diseases. I. Amyotrophic lateral sclerosis (motor neurone disease);Emery;Neuromuscul Disord,1991
3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol,2010
4. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;Manzur;Cochrane Database Syst Rev,2008
5. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy;Ricotti;J Neurol Neurosurg Psychiatry,2013
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Longitudinal changes in magnetic resonance imaging biomarkers of the gluteal muscle groups and functional ability in Duchenne muscular dystrophy: a 12-month cohort study;Pediatric Radiology;2023-10-27
2. Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy;Health and Quality of Life Outcomes;2023-07-19
3. Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy;PLOS ONE;2023-04-26
4. Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy;CPT: Pharmacometrics & Systems Pharmacology;2023-02-14
5. Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status;Journal of Comparative Effectiveness Research;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3